SynthesisFrontiers in public health2025
Prenatal PM2.5 exposure and hypertensive disorders of pregnancy: a systematic review and meta-analysis.
Synthesis in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study endeavors to unravel the association between PM2.5 exposure and hypertensive disorders of pregnancy (HDP) via a comprehensive review of epidemiological studies. Methods: Pertinent studies investigating the association between PM2.5 exposure and HDP were retrieved from PubMed, Embase, Web of Science, and the Cochrane Library until June 20, 2024. In addition, one article was identified through an updated search on September 1, 2025. Our study utilized the Newcastle-Ottawa Scale (NOS) and the Journal of Biomedical Informatics (JBI) scale for eligible study quality assessment. Statistical analyses were enabled by R 4.3.2 and Stata 15.1. Results: Fifteen studies were encompassed, involving 78,427 patients. The meta-analysis revealed the following rates and 95% confidence intervals (CIs): preeclampsia (PE) at 3% (2.9-3.7%); gestational hypertension (GH) at 3% (1.9-4.4%); and HDP at 11.2% (2.1-26%). For the entire pregnancy period, analysis showed a positive association between PM2.5 and PE (OR: 1.11, 95% CI: 1.06, 1.15). In different pregnancy periods, analysis revealed a positive association of PM2.5 with PE (OR: 1.02, 95% CI: 1.01, 1.03). At PM2.5 levels in the third quartile (Q3), analysis showed a positive association with PE (OR: 1.12, 95% CI: 1.07, 1.18). Similarly, at PM2.5 levels in the fourth quartile (Q4), the association was significant (OR: 1.18, 95% CI: 1.12, 1.24). For PM2.5 levels in the second quartile (Q2), a positive association with HDP prevalence was observed (OR: 1.11, 95% CI: 1.00, 1.23). Other analyses suggested that PM2.5 is a risk factor for HDP, though our results lacked statistical significance. Conclusion: Our study indicates that PM2.5 is a significant risk factor for HDP. Due to several limitations, it was anticipated that future large-scale, multicenter, prospective studies will provide further confirmation of these findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.